(TSX-V:RX), MISSISSAUGA, Ontario, Nov. 20, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q3) and nine months (YTD) ended September 30, 2025. Key highlights include: (CAD) Q3 2025 % Change vs.Q3 2024 YTD 2025 % Change vs.YTD 2024 Trailing Twelve Months (TTM) Sept 30, […]
Namib Minerals Schedules Business Update Call Call scheduled for 8:00 AM ET on Monday, November 24, 2025 GlobeNewswire November 20, 2025 NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) — Namib Minerals (“Namib Minerals” or “the Company”), (Nasdaq: NAMM), an established African gold producer with a portfolio of mining and exploration assets in Zimbabwe and the
Global Insight Consulting LLC Accelerates Regional Growth With Large-Scale Hiring Initiative Across Southeast Asias GlobeNewswire November 20, 2025 Denver, CO, Nov. 20, 2025 (GLOBE NEWSWIRE) — Global Insight Consulting LLC (GIC), a U.S.-based provider of data research and content evaluation services, announced today a major expansion plan to significantly scale its international recruitment over the
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Exact Sciences Corporation (NASDAQ: EXAS) GlobeNewswire November 20, 2025 NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a
BioSyent Releases Financial Results for Q3 and YTD 2025 GlobeNewswire November 20, 2025 MISSISSAUGA, Ontario, Nov. 20, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q3) and nine months (YTD) ended September 30, 2025. Key highlights include: (CAD) Q3 2025 % Change vs.Q3 2024
(TSX-V:RX), MISSISSAUGA, Ontario, Nov. 20, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common share, payable in Canadian Dollars on December 15, 2025, to shareholders of record at the close of business on November
BioSyent Declares Fourth Quarter 2025 Dividend GlobeNewswire November 20, 2025 MISSISSAUGA, Ontario, Nov. 20, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common share, payable in Canadian Dollars on December 15, 2025, to shareholders
ASTHO Chief Medical Officer Susan Kansagra, MD, MBA made the following statement regarding vaccines and autism: https://mma.prnewswire.com/media/708096/ASTHO_Logo.jpg “As public health professionals, we unequivocally support the use of vaccines to prevent infectious diseases. The science behind vaccines is robust and well-tested and the overwhelming consensus of scientific evidence is clear that there is no link between
The Illinois personal injury and medical malpractice law firm of Salvi, Schostok & Pritchard P.C. is pleased to announce attorney John A. Mennie has been promoted to Partner. John A. Mennie joined Salvi, Schostok & Pritchard P.C. in 2014 as a staff attorney and was promoted to associate in 2016. Named Partner in November 2025,
CORAL GABLES, FL / ACCESS Newswire / November 20, 2025 / Just off Dixie Highway, across from the University of Miami and steps away from the scent of fresh pastries drifting from Madruga Bakery, a new kind of health destination has arrived in Coral Gables. Relive Health, a nationally recognized leader in longevity and aesthetics,